GC18015
LY2157299
Also known as 4-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide
LY2157299 is an oral and selective TGF-β receptor type I (TGF-βRI) kinase inhibitor with an IC50 value of 56nM
ChemicalCAS700874-72-2MW369.42FormulaC22H19N5O
- CAS number
- 700874-72-2
- Molecular weight
- 369.42
- Formula
- C22H19N5O
- Solubility
- ≥ 18·45mg/mL in DMSO
- InChIKey
- IVRXNBXKWIJUQB-UHFFFAOYSA-N
- Catalogue number
- GC18015
- Brand
- GLPBIO
Computed properties PubChem CID 10090485 · XLogP 2.4 · TPSA 86.7 Ų · H-bond donors 1
- XLogP
- 2.4
- TPSA
- 86.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 3
- Heavy atoms
- 28
SMILES CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N
Computed descriptors from PubChem (CID 10090485), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il